Management of patients with allergic diseases during pregnancy: lecture


ABSTRACT. In connection with the considerable increase of prevalence of allergic diseases (AD) there all more often are situations, when it will be to decide the question of management of patients a doctor with an allergy during pregnancy. Prevalence of AD (allergic rhinitis/conjunctivitis, allergic phenotypes of bronchial asthma and hives, atopic dermatitis, food/drug/insect allergy, anaphylaxis) among pregnant women can arrive 30 %. It is possible to distinguish three types of influence of pregnancy on clinical motion of AD: 1) presence of pregnancy does not affect motion of AD; 2) on a background pregnancy comes remission of AD; 3) on a background pregnancy arise up intensifying of AD and their motion are burdened. It is difficult to predict exactly how the course of AD will occur during pregnancy, while the nature of treatment of a pregnant woman with AD and the level of their control are extremely important. At pregnancy diagnosis of AD is based on data of allergic anamnesis, food diary, physical inspection. Thus realization of skin and provocative tests with allergens contra-indicated. Application of provocative tests is also forbidden with a histamine, а methacholine and an acetylcholine. At treatment of pregnant from AD must be taken into account possible side effects of antiallergic drugs. Setting of modern medicinal facilities allows in most cases to control motion of allergic pathology for pregnant and avoid development of side effects of drugs. Treatment of AD during pregnancy the best result must provide for a mother and child. Medical workers must inform the women of reproductive age and pregnant of potential risks and present/absent proofs of unconcern/ununconcern of diagnostic and curative events.

Keywords: allergic diseases, pregnancy, patient management


Alioshyna R.M. Alerhichni zakhvoryuvannya ta vahitnist. Klinichna imunolohiya. Allerholohiya. Infektolohiya. 2010; 4: 39-49.

Dombrovskaya D.K. i dr. Atopicheskiy dermatit i beremennost. Zhurnal akusherstva i zhenskikh bolezney. 2012; 61 (5): 112-114.

Zaikov S.V., Mykhalchuk N.A. Ratsyonalnaia terapyia allerhycheskykh zabolevanyi u beremennykh. Klinichna imunolohiia. Alerholohiia. Infektolohiia. 2008; 3/1 (spetsvypusk): 54-60.

Zaikov S.V., Gryshylo P.V., Gryshylo A.P. Mozhlyvosti vykorystannya antyhistaminnykh preparativ pid chas vahitnosti. Klinichna imunolohiya. Allerholohiya. Infektolohiya. 2020; 123: 12-17.

Kolkhir P.V. Dokazova alerholohiya-imunolohiya. M.: Praktychna medytsyna, 2010. P. 269-299.

Patterson R., Hremmer L.K., Hrinberher P.A. Alerhichni khvoroby: diahnostyka ta likuvannya. M: Heotar Medytsyna. 2000. 768 p.

Feshchenko Yu.I., Boyko D.M., Gavrysiuk V.K. ta in. Bronkhialna astma. Adaptovana klinichna nastanova, zasnovana na dokazakh. K.: Natsionalna akademiia medychnykh nauk Ukrainy. 2019. 114 p.

Abdullah K., Zhu J., Gershon A., Dell S., To T. Effect of asthma exacerbation during pregnancy in women with asthma: a population-based cohort study. Eur. Respir. J. 2020; 55: 1901335. doi: 10.1183/13993003.01335-2019.

Agache I., Akdis C., Akdis M., et al. EAACI Biologicals Guidelines – recommendations for severe asthma. Allergy. 2021; 76 (1): 14-44. doi: 10.1111/all.14425.

Agache I., Akdis S.A., Chivato T., et al. EAACI White Paper in Research, Innovation and Quality Care, 2018. 152 p.

Agache I., Rocha C., Beltran J., et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: a systematic review for the EAACI Guidelines – recommendations on the use of biologicals in severe asthma. Allergy. 2020; 75 (5): 1043-1057.

Agache I., Rocha C., Pereira A., et al. Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: a systematic review for the EAACI Biologicals Guidelines. Allergy. 2021; 76 (1): 59-70. doi: 10.1111/all.1454768.

Agache I., Song Y., Rocha C., et al. Efficacy and safety of treatment with dupilumab for severe asthma: a systematic review of the EAACI Guidelines – recommendations on the use of biologicals in severe asthma. Allergy. 2020; 75 (5): 1058-1068. doi: 10.1111/all.14268.

Akbari M., Shah S., Velayos F.S., Mahadevan U., Cheifetz A.S. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm. Bowel. Dis. 2013; 19 (1): 15-22.

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines – 2016 revision. J. Allergy Clin. Immunol. 2017 Oct; 140 (4): 950-958. doi: 10.1016/j.jaci.2017.03.050. Epub 2017 Jun 8.

Babalola O., Strober B.E. Treatment of atopic dermatitis in pregnancy. Dermatol. Ther. 2013; 26: 293-301.

Bakhireva L.N., Jones K.L., Schatz M., et al. Safety of leukotriene receptor antagonists in pregnancy. J. Allergy Clin. Immunol. 2007; 119 (3): 618-625.

Bay Bjorn A.M., Ehrenstein V., Hundborg H.H., Nohr E.A., Sorensen H.T., Norgaard M. Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring. Am. J. Ther. 2014; 21 (2): 73-80.

Berard A., Sheehy O., Kurzinger M.L., Juhaeri J. Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes. J. Allergy Clin. Immunol. 2016; 138 (1): 97-104. e107.

Blaiss M.S., Food and Drug Administration (U.S.). ACAAI-ACOG (American College of Allergy Asthma, and Immunology and American College of Obstetricians and Gynecologists). Management of rhinitis and asthma in pregnancy. Ann. Allergy Asthma Immunol. 2003; 90: 16-22.

Boccon-Gibod I., Bouillet L. Angioedema and urticaria. Ann. Dermatol. Venereol. 2014; 141 (Suppl. 3): 586-595.

Caparroza F.A., Gregorioa L.L., Bon Suemy G.C., et al. Rhinitis and pregnancy: literature review. Brazilian Journal of Otorhinolaryngology. 2015 Apr.

Chi C.C., Kirtschig G., Aberer W., et al. Updated evidence-based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy. J. Eur. Acad. Dermatol. Venereol. 2017; 31 (5): 761-773.

Chi C.C., Wang S.H., Wojnarowska F., Kirtschig G., Davies E., Bennett C. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst. Rev. 2015; 10: CD007346. doi: 10.1002/14651858.CD007346.

Choo K.J., Simons F.E., Sheikh A. Glucocorticoids for the treatment of anaphylaxis. Cochrane Database Syst. Rev. 2012; 4: CD007596. doi: 10.1002/14651858.CD007596.pub3].

Cohen J.M., Bateman B.T., Huybrechts K.F., et al. Poorly controlled asthma during pregnancy remains common in the United States. J. Allergy Clin. Immunol. Pract. 2019; 7 (8): 2672-2680. e2610.

Cossette B., Beauchesne M.F., Forget A., et al. Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy. Ann. Allergy Asthma Immunol. 2014; 112 (5): 459-464.

Dombrowski M.P., Schatz M., Wise R., et al. Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy. Am. J. Obstet. Gynecol. 2004; 190 (3): 737-744.

Dombrowski M.P., Schatz M. ACOG Committee on Practice Bulletins–Obstetrics. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008: asthma in pregnancy. Obstet. Gynecol. 2008; 111 (2 Pt. 1): 457-464.

Eiwegger T., Hung L., San Diego K.E., O’Mahony L., Upton J. Recent developments and highlights in food allergy. Allergy. 2019; 74 (12): 2355-2367.

Ellegard E.R. Clinical and pathogenetic characteristics of pregnancy rhinitis. Clin. Rev. Allergy Immunol. 2004; 26: 149-159.

Ellegard E. Special considerations in the treatment of pregnancy rhinitis. Womens Health (Lond. Engl.). 2005; 1: 105-114.

Eltonsy S., Forget A., Blais L. Beta2-agonists use during pregnancy and the risk of congenital malformations. Birth Defects Res. A Clin. Mol. Teratol. 2011; 91 (11): 937-947.

FDA Announcement. Available at:

Ghazeeri G., Kibbi A.G., Abbas O. Pruritic urticarial papules and plaques of pregnancy: epidemiological, clinical, and histopathological study of 18 cases from Lebanon. Int. J. Dermatol. 2012; 51 (9): 1047-1053.

Gilbertt C., Mazzotta P., Loebstein R., Koren G. Fetal safety of drugs used in the treatment of allergic rhinitis: a critical review. Drug Saf. 2005; 28: 707-719.

Gilbey P., McGruthers L., Morency A.M., Shrim A. Rhinosinusitis-related quality of life during pregnancy. Am. J. Rhinol. Allergy. 2012; 26: 283-286.

Gilboa S.M., Ailes E.C., Rai R.P., Anderson J.A., Honein M.A. Antihistamines and birth defects: a systematic review of the literature. Expert Opin. Drug Saf. 2014; 13 (12): 1667-1698.

Gilboa S.M., Strickland M.J., Olshan A.F., Werler M.M., Correa A., National Birth Defects Prevention Study. Use of antihistamine medications during early pregnancy and isolated major malformations. Birth Defects Res. A Clin. Mol. Teratol. 2009; 85 (2): 137-150.

GINA: Global Strategy For Asthma Management And Prevention. Updated 2022. Available at:

Gluck P.A., Gluck J.C. A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide. Curr. Med. Res. Opin. 2005; 21: 1075-1084.

Hoeltzenbein M., Elefant E., Vial T., et al. Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. Am. J. Med. Genet. A. 2012; 158A (3): 588-596.

Heinonen O.P., Slone D., Shapiro S. Birth defects and drugs in pregnancy. PSG Publishing, Littleton, MA. 1977.

Incaudo G.A., Takach P. The diagnosis and treatment of allergic rhinitis during pregnancy and lactation. Immunol. Allergy Clin. North Am. 2006; 26: 137-154.

Kage P., Simon J.C., Treudler R. A case of atopic eczema treated safely with dupilumab during pregnancy and lactation. J. Eur. Acad. Dermatol. Venereol. 2020; 34: e256-257.

Kage P., Simon J., Treudler R. Atopic dermatitis and psychosocial comorbidities. JDDG. 2020; 18: 93-102.

Kallen B. Use of antihistamine drugs in early pregnancy and delivery outcomes. J. Matern. Fetal. Neonatal. Med. 2002; 11: 146-152.

Kallen B., Olausson P.O. Monitoring of maternal drug use and infant congenital malformations. Does loratadine cause hypospadias? Int. J. Risk Saf. Med. 2001; 14: 115-119.

Kallen B., Rydhstroem H., Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet. Gynecol. 1999; 93 (3): 392-395.

Katoh N., Ohya Y., Ikeda M., et al. Japanese guidelines for atopic dermatitis 2020. Allergol. Int. 2020; 69: 356-369.

Kemp M.W., Newnham J.P., Challis J.G., Jobe A.H., Stock S.J. The clinical use of corticosteroids in pregnancy. Hum. Reprod. Update. 2016; 22 (2): 240-259.

Kircher S., Schatz M., Long L. Variables affecting asthma course during pregnancy. Ann. Allergy Asthma Immunol. 2002; 89 (5): 463-466.

Koutroulis I., Papoutsis J., Kroumpouzos G. Atopic dermatitis in pregnancy: current status and challenges. Obstet. Gynecol. Surv. 2011; 66: 654-663.

Lin S., Munsie J.P., Herdt-Losavio M.L., et al. Maternal asthma medication use and the risk of selected birth defects. Pediatrics. 2012; 129 (2): e317-e324.

Malka I., Michael M. Safety of common medications for treating dermatology disorders in pregnant women. Curr. Derm. Rep. 2013; 2: 249-257.

Martel M.J., Rey E., Beauchesne M.F., et al. Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study. BMJ. 2005; 330 (7485): 230.

Matz H., Orion E., Wolf R. Pruritic urticarial papules and plaques of pregnancy: polymorphic eruption of pregnancy (PUPPP). Clin. Dermatol. 2006; 24 (2): 105-108.

Mian M., Dunlap R., Simpson E. Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: a case report. JAAD Case Rep. 2020; 6 (10): 1051-1052.

Middleton P.G., Gade E.J., Aguilera C., et al. ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases. Eur. Respir. J. 2020; 55 (2): 1901208.

Munsie J.W., Lin S., Browne M.L., et al. Maternal bronchodilator use and the risk of orofacial clefts. Hum. Reprod. 2011; 26 (11): 3147-3154.

Murphy V.E., Jensen M.E., Gibson P.G. Asthma during pregnancy: exacerbations, management, and health outcomes for mother and infant. Semin. Respir. Crit. Care Med. 2017; 38 (2): 160-173.

Namazy J.A., Asthma S.M. Allergic and immunologic diseases during pregnancy: a guide to management. 2019th ed. Springer Nature Switzerland AG. 2019.

Namazy J.A., Blais L., Andrews E.B., et al. Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort. J. Allergy Clin. Immunol. 2020; 145 (2): 528-536. e521.

Namazy J.A., Murphy V.E., Powell H., Gibson P.G., Chambers C., Schatz M. Effects of asthma severity, exacerbations and oral corticosteroids on perinatal outcomes. Eur. Respir. J. 2013; 41 (5): 1082-1090.

Namazy J.A., Schatz M. Asthma and rhinitis during pregnancy. MtSinai J. Med. 2011; 78: 661-670.

Namazy J.A., Schatz M. Pharmacological difficulties in the treatment of asthma in pregnant women. Expert Rev. Clin. Pharmacol. 2017; 10 (3): 285-292.

Namazy J.A., Schatz M. The safety of intranasal steroids during pregnancy: a good start. J. Allergy Clin. Immunol. 2016; 138: 105.

National Heart, Lung, and Blood Institute. National Asthma Education, and Prevention Program Asthma, and Pregnancy Working Group. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment – 2004 update. J. Allergy Clin. Immunol. 2005; 115 (1): 34-46.

NGA. Intrapartum care for women with existing medical conditions or obstetric complications and their babies. (UK) NGA. 2019.

Nurmatov U.B., Rhatigan E., Simons F.E., Sheikh A. H2-antihistamines for the treatment of anaphylaxis with and without shock: a systematic review. Ann. Allergy Asthma Immunol. 2014; 112 (2): 126-131.

Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann. Nutr. Metab. 2015; 66: 8-16.

Odedra K.M. Treatment of rhinitis in pregnancy. Nurs. Stand. 2014; 29 (8): 37-41.

Oykhman P., Kim H.L., Ellis A.K. Allergen immunotherapy in pregnancy. Allergy Asthma Clin. Immunol. 2015; 11: 31.

Pali-Schöll I., Namazy J., Jensen-Jarolim E. Allergic diseases and asthma in pregnancy, a secondary publication. World Allergy Organization Journal. 2017; 10: 10.

Palmer G.W., Claman H.N. Pregnancy and immunology: selected aspects. Ann. Allergy Asthma Immunol. 2002; 89: 350.

Palomares O., Untersmayr E., Gutermuth J., et al. Biologicals in allergic diseases and asthma: toward personalized medicine and precision health: highlights of the 3rd EAACI Master Class on Biologicals, San Lorenzo de El Escorial, Madrid, 2019. Allergy. 2020; 75 (4): 936-940.

Pariser D. Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption. Am. J. Ther. 2009; 16 (3): 264-273.

Paziana K., Del Monaco M., Cardonick E., et al. Ciclosporin use during pregnancy. Drug Saf. 2013; 36 (5): 279-294.

Perkins A., Einion A. Pregnant pause: should we screen for sleep disordered breathing in pregnancy? Breathe (Sheff). 2019; 15 (1): 36-44.

Pfaller B., Bendien S., Ditisheim A., Eiwegger T. Management of allergic diseases in pregnancy. Allergy. 2022; 77: 798-811. doi: 10.1111/all.15063.

Pfaller B., Yepes-Nunez J.J., Agache I., et al. Biologicals in atopic disease in pregnancy: an EAACI position paper. Allergy. 2021; 76 (1): 71-89. doi: 10.1111/all.14282.

Pier J., Bingemann T.A. Urticaria, angioedema, and anaphylaxis. Pediatrics in Review. 2020; 41 (6): 283-292. doi: 10.1542/pir.2019-0056.

Piette V., Daures J.P., Demoly P. Treating allergic rhinitis in pregnancy. Curr. Allergy Asthma Rep. 2006; 6: 232-238.

Porsbjerg C., Menzies-Gow A. Co-morbidities in severe asthma: clinical impact and management. Respirology. 2017; 22 (4): 651-661.

Powell R.J., Leech S., Till S., Huber P.A.J., Nasser S.M., Clark A.T., et al. BSACI guideline for the management of chronic urticaria and angioedema. Clin. Exp. Allergy. 2015; 45 (3): 547-565. doi: 10.1111/cea.12494.

Prasad B., Nyenhuis S.M., Imayama I., Siddiqi A., Teodorescu M. Asthma and obstructive sleep apnea overlap: what has the evidence taught us? Am. J. Respir. Crit. Care Med. 2020; 201 (11): 1345-1357.

Radonjic-Hoesli, et al. Urticaria and angioedema: an update on classification and pathogenesis. Clin. Rev. Allergy Immunol. 2018 Feb; 54 (1): 88-101.

Rayburn W.F., Anderson J.C., Smith C.V., et al. Uterine and fetal Doppler flow changes from a single dose of a long-acting intranasal decongestant. Obstet. Gynecol. 1990; 76: 180.

Roberts G., Pfaar O., Akdis C.A., et al. EAACI Guidelines on Allergen Immunotherapy: allergic rhinoconjunctivitis. Allergy. 2018; 73 (4): 765-798.

Robijn A.L., Brew B.K., Jensen M.E., et al. Effect of maternal asthma exacerbations on perinatal outcomes: a population-based study. ERJ Open Res. 2020; 6 (4): 00295-2020.

Robijn A.L., Murphy V.E., Gibson P.G. Recent developments in asthma in pregnancy. Curr. Opin. Pulm. Med. 2019; 25 (1): 11-17.

Sarkar M., Koren G., Kalra S., et al. Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes. Eur. J. Clin. Pharmacol. 2009; 65 (12): 1259-1264.

Schattz M., Zeiger R.S. Asthma and allergic rhinitis during the pregnancy. Ann. Allergy. 1990; 65: 427.

Schatz M., Zeiger R.S., Harden K., Hoffman C.C., Chilingar L., Petitti D. The safety of asthma and allergy medications during pregnancy. J. Allergy Clin. Immunol. 1997; 100 (3): 301-306.

Seto A., Einarson T., Koren G. Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis. Am. J. Perinatol. 1997; 14 (3): 119-124.

Shaikh W.A., Shaikh S.W. A prospective study on the safety of sublingual immunotherapy in pregnancy. Allergy. 2012; 67 (6): 741-743.

Sheikh A., Shehata Y.A., Brown S.G., Simons F.E. Adrenaline for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2009; 64 (2): 204-212.

Simons F.E., Schatz M. Anaphylaxis during pregnancy. J. Allergy Clin. Immunol. 2012; 130 (3): 597-606.

Somoskövi A., Bártfai Z., Tamási L., et al. Population-based case-control study of allergic rhinitis during pregnancy for birth outcomes. Eur. J. Obstet. Gynecol. Reprod. Biol. 2007; 131: 21.

Vestergaard C., Wollenberg A., Barbarot S., et al. European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period. Journal of the European Academy of Dermatology and Venereology. 2019; 33 (9): 1644-1659.

Vestergaard C., Wollenberg A., Thyssen J.P. European Task Force on Atopic Dermatitis (ETFAD) Position Paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period. J. Eur. Acad. Dermatol. Venereol. 2020; 34: 426-427.

Vultaggio A., Agache I., Akdis C.A., et al. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: an EAACI statement. Allergy. 2020; 75 (11): 2764-2774.

Wallace D.W., Dykewicz M.S., et al. The diagnosis and management of rhinitis: an update practice parameter. J. Allergy Clin. Immunol. 2008 Aug; 122: 1-84.

Weber-Schoendorfer C., Chambers C., Wacker E., et al. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study. Arthritis Rheumatol. 2014; 66 (5): 1101-1110.

Wise S.K., Lin S.Y., Toskala E., et al. International consensus statement on allergy and rhinology. International Forum of Allergy & Rhinology. 2018; 2: 109-352.

Yau W.P., Mitchell A.A., Lin K.J., Werler M.M., Hernández-Díaz S. Use of decongestants during pregnancy and the risk of birth defects. Am. J. Epidemiol. 2013; 178: 198-208.

Zuberbier T. Urticaria. Allergy. 2003; 58: 1224-1234.

Zuberbier T., Abdul Latiff A.H., Abuzakouk M., et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2021 Sep 18. doi: 10.1111/all.15090. Epub ahead of print. PMID: 34536239.

Zuberbier T., Aberer W., Asero R., Abdul Latiff A.H., Baker D., Ballmer-Weber B., et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. The 2017 revision and update. Allergy. 2018; 73 (7): 1393-1414. doi: 10.1111/all.13397.

Zuberbier T., Grattan C., Maurer M. Urticaria and angioedema. Dordrecht: Springer, 2010. – 156 p.

How to Cite
Zaikov, S., Bogomolov, A., Hritsova, N., & GrуshуloA. (2022). Management of patients with allergic diseases during pregnancy: lecture. Infusion & Chemotherapy, (3), 42-53.

Author Biographies

S.V. Zaikov, National University of Healthcare of Ukraine named after P.L. Shupyk, Kyiv, Ukraine; SI «National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky of the NAMS of Ukraine», Kyiv, Ukraine

Zaikov Serhii Victorovych
Professor of the department of phthisiology and pulmonology
MD, professor.
9, Dorohozhytska st., Kyiv, 04112, Ukraine.

A.Ye. Bogomolov, Vinnytsia National Medical University named after M.I. Pyrogov, Vinnytsia, Ukraine

Bogomolov Artemii Yevgenovych
Professor of the department of phthisiology, clinical immunology and allergology,
MD, professor.
56, M. Pyrogov st., Vinnytsia, 21018, Ukraine.

N.A. Hritsova, National University of Healthcare of Ukraine named after P.L. Shupyk, Kyiv, Ukraine; SI «National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky of the NAMS of Ukraine», Kyiv, Ukraine

Hritsova Nataliia Anatoliivna
Associate professor of the department of phthisiology and pulmonology
9, Dorohozhytska st., Kyiv, 04112, Ukraine.

A.P. Grуshуlo, Private Clinic “Medicom”, Kyiv, Ukraine

Gryshylo Anton Pavlovych
Pulmonologist and allergist of the private clinic “Medicom”.
6d, Heroev Stalingrada ave., Kyiv, 04211, Ukraine.